Skip to main content

GOLDMAN SACHS GROUP INC

Position in STOK — Stoke Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,825,254
-$8,222,402 QoQ
Shares Held
575,344
-30.7% QoQ
Ownership
0.892%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. STOK ranks #117 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STOK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,825,254 575,344
2026-03-31 $27,047,656 830,702
2025-12-31 $36,270,471 1,142,737
2025-09-30 $27,046,831 1,150,929
2025-06-30 $14,770,673 1,301,381
2025-03-31 $11,052,558 1,662,039
2024-12-31 $15,099,705 1,368,967
2024-09-30 $17,129,309 1,393,760
2024-06-30 $18,475,153 1,367,517
2024-03-31 $18,954,742 1,404,055
2023-12-31 $7,318,926 1,391,431
2023-09-30 $509,460 129,305
2023-06-30 $993,915 93,501
2023-03-31 $684,492 82,172
2022-12-31 $626,365 67,862
2022-09-30 $1,441,494 112,266
2022-06-30 $1,608,805 121,787
2022-03-31 $2,400,583 114,042
2021-12-31 $3,030,680 126,331
2021-09-30 $4,394,733 172,749
2021-06-30 $4,590,819 136,388
2021-03-31 $21,687,206 558,373
2020-12-31 $35,731,752 576,970
2020-09-30 $3,633,798 108,504
2020-06-30 $3,412,074 143,184
2020-03-31 $479,892 20,956